PPARs are members of the nuclear hormone receptor superfamily and are primarily involved in lipid metabolism. The expression patterns of all 3 PPAR isotypes in 22 adult rat organs were analyzed by a quantitative ribonuclease protection assay. The data obtained allowed comparison of the expression of each isotype to the others and provided new insight into the less studied PPAR␤ (NR1C2) expression and function. This isotype shows a ubiquitous expression pattern and is the most abundant of the three PPARs in all analyzed tissues except adipose tissue. Its expression is especially high in the digestive tract, in addition to kidney, heart, diaphragm, and esophagus. After an overnight fast, PPAR␤ mRNA levels are dramatically down-regulated in liver and kidney by up to 80% and are rapidly restored to control levels upon refeeding. This tight nutritional regulation is independent of the circulating glucocorticoid levels and the presence of PPAR␣, whose activity is markedly up-regulated in the liver and small intestine during fasting. Finally, PPAR␥2 mRNA levels are decreased by 50% during fasting in both white and brown adipose tissue. In conclusion, fasting can strongly influence PPAR expression, but in only a few selected tissues. 
P PARs ARE LIGAND-ACTIVATED transcription factors
belonging to the nuclear hormone receptor superfamily. This superfamily is characterized by a common structural organization in functional domains: the aminoterminal A/B domain mediates ligand-independent transactivation functions; the C domain contains a highly conserved zinc finger structure forming the DNA-binding domain and a dimerization interface; the D domain is a structurally poorly defined hinge region; the carboxylterminal E/F domain or ligand-binding domain mediates ligand-dependent transactivation and dimerization (1) . Three PPAR isotypes, i.e. PPAR␣ (NR1C1); PPAR␤ (NR1C2), which is also called PPAR␦, NUC-1, or FAAR; and PPAR␥ (NR1C3), have been reported in vertebrates as primitive as cyclostoma (2) , in lower vertebrates (3) , and in mammals (4) . In mammals, alternative promoter usage and differential splicing of the ppar␥ gene transcripts yield two isoforms, ␥1 and ␥2 (5). In human, a PPAR␥3 mRNA is transcribed from a third promoter, resulting in a protein identical to PPAR␥1 (6) .
PPAR heterodimerizes with the 9-cis RXR to bind DR1 (direct repeat spaced by 1 bp) response elements, called PPAR response element, identified in the promoters of target genes involved in microsomal -hydroxylation, peroxisomal ␤-oxidation, mitochondrial ␤-oxidation, ketogenesis, lipoprotein metabolism, fatty acid binding, and fatty acid transport (7) . Various ligands have been described for PPARs: natural fatty acids, especially polyunsaturated ones; arachidonate derivatives; hypolipidemic fibrates; and insulin-sensitizing thiazolidinediones (8) . The nature of these PPAR ligands together with the function of identified target genes suggest that PPARs play a key role in lipid and glucose metabolism and homeostasis. PPARs are expressed in a broad range of tissues in adult rodents, as previously shown by in situ hybridization (9) . PPAR␣ is expressed in cells with high catabolic rates of fatty acids and high peroxisomedependent activities (hepatocytes, cardiomyocytes, proximal tubules of kidney, brown adipocytes, and intestinal mucosa) (4, 9) . PPAR␣-null mutant mice allowed identification of this isotype as a mediator of the pleiotropic effects of peroxisome proliferators in liver (10) . This isotype is the best studied to date during fasting. Elevated glucocorticoid hormone levels, observed during fasting and stress, up-regulate hepatic PPAR␣ expression at the transcriptional level through binding of GRs to response elements located in the promoter of PPAR␣ (11) (12) (13) (14) (15) . The critical role of PPAR␣ in lipid catabolism as well as glucose homeostasis is revealed unequivocally during fasting, where PPAR␣-null mutant mice show abnormally elevated FFA fasting levels. This indicates a dramatic inhibition of hepatic fatty acid oxidation that results in hepatic steatosis, myocardial lipid accumulation, hypoketonemia, hypoglycemia, and hypothermia (16, 17) . PPAR␤ is expressed ubiquitously and is abundant in most tissues (4, 9, 18) . PPAR␤ (also often called PPAR␦) function has been recently linked to basal lipid metabolism, embryo implantation, colon cancer, and inflammation (19 -22) . PPAR␥ expression is restricted mainly to adipose tissue and large intestine, with some expression in parts of the immune system (4, 9) . Several loss of function experiments in mice have shown that PPAR␥ is important in placental development and is required for adipogenesis in vivo (23) (24) (25) .
Previous in situ hybridization studies in adult rat have demonstrated that PPARs are expressed in specific cell populations or restricted areas of a given tissue (9) . However, information concerning the relative expression level of each PPAR isotype with respect to the two others is presently lacking. We thus quantitatively studied PPAR mRNA ex-pression for each of the three PPAR isotypes by ribonuclease (RNase) protection assay in 22 different organs of the adult rat in the fed state, during an overnight fast, and after refeeding. This provides valuable physiological information about the particular and sometimes opposite effects for which the three PPAR isotypes are responsible.
Materials and Methods

Cloning of the rat PPARs
The full-length cDNAs of rat PPARs were obtained by RT-PCR, using the Expand Reverse Kit (Roche Molecular Biochemicals, Indianapolis, IN). Total rat liver RNA was used for cloning rat (r)PPAR␣ and rPPAR␤ and total white adipose tissue (WAT) RNA for cloning rPPAR␥1 and rPPAR␥2, with the following downstream primers in the reverse transcriptase reaction: 5Ј-ATCTCAGGATCCATCAGTA-CATGTCTCTGT-3Ј (rPPAR␣), 5Ј-CTGCGTGGATCCTTAGTACAT-GTCCTTGTA-3Ј (rPPAR␤), and 5Ј-GGTGGGGAATTCCTGCTAAT-ACAAGTCCTT-3Ј (rPPAR␥).
The following upstream primers were added for subsequent PCR amplification: 5Ј-CCACAAGGATCCAACATGGTGGACACAGAG-3Ј (rP-PAR␣), 5Ј-CAAGTGGGATCCGTCATGGAACAGCCACAG-3Ј (rPPAR␤), 5Ј-TTACTGGAATTCCCATGGTTGACACAGAGA-3Ј (rPPAR␥1), and 5Ј-TCTGTTGAATTCTGTTATGGGTGAAACTCT-3Ј (rPPAR␥2).
The PCR products were subcloned by using the Rapid DNA Ligation Kit (Roche Molecular Biochemicals) into pCRII vector (Invitrogen, San Diego, CA) resulting in pCR-rPPAR␣, pCR-rPPAR␤, pCR-rPPAR␥1, and pCR-rPPAR␥2 recombinant vectors. Two independent clones of each isotype and isoform were sequenced manually on both strands using the T7 Polymerase Sequencing Kit with [␣- 35 
Probes for RNase protection assay
A BamHI/EcoRI fragment was excised from a partial L27 (large ribosomal subunit, 27-kDa protein) cDNA [155-374 nucleotides (nt)] (11) and subcloned into the pBluescript KS Ϫ vector (Stratagene, La Jolla, CA). The resulting construct pBS-L27 (150 nt) was digested by EcoRI, transcribed by T7 polymerase (Promega Corp.) yielding a 200-bp riboprobe and a digested fragment of 150 bp. We used a previously described 287-bp probe located in the E/F domain to assess rPPAR␣ mRNA expression (11) . The plasmid pCR-rPPAR␤ was digested by XbaI and BglII and the 171-bp fragment containing the 3Ј-end of the E/F domain subcloned into the pBluescript SK ϩ vector (Stratagene) digested by XbaI and BamHI to obtain the recombinant plasmid pBS-rPPAR␤ (171 nt). A 215-bp antisense probe was synthesized by T7 RNA polymerase (Promega Corp., Madison, WI) transcription of pBS-rPPAR␤ (171 nt) linearized by XbaI, resulting in a protected fragment of 171 bp for rPPAR␤. The plasmid pCR-rPPAR␥2 was digested by PvuII and EcoRI, and the 351-bp fragment containing the 5Ј of the A/B domain was subcloned into the pBluescript KS ϩ vector (Stratagene) digested by SmaI and EcoRI to obtain the recombinant plasmid pBS-rPPAR␥ (351 nt). A 409-bp antisense riboprobe was synthesized by T7 RNA polymerase (Promega Corp.) transcription of this plasmid linearized by HindIII, resulting in a protected fragment of 351 bp for rPPAR␥2 and 257 bp for rPPAR␥1. The GϩC content of the probes is 51.2% for rPPAR␣, 60.2% for rPPAR␤, 51.4% for rPPAR␥1, and 50.4% for rPPAR␥2, with calculated T m of 73.0, 71.7, 72.8, and 73.4 C, respectively.
To assess mRNA expression of mouse PPARs, we constructed the following probes. A BamHI/KpnI fragment (nt 160 -503 of GenBank accession no. X57638) encoding the A/B domain was excised off a pSG5-mouse (m)PPAR␣ vector and subcloned into the BamHI/KpnI sites of pBluescript SK ϩ (Stratagene). The recombinant plasmid pBSmP-PAR␣ (333 nt) was linearized by XbaI, and a 369-bp antisense riboprobe was transcribed by T7 RNA polymerase (Promega Corp.), yielding a protected fragment of 333 bp. A pSG5-mPPAR␤ vector was digested by SmaI/XhoI, and a fragment coding for partial A/B and C domains (nt 31-315 of GenBank accession no. U10375) was subcloned into pBluescript KS ϩ (Stratagene). The recombinant plasmid pBSmPPAR␤ (288 nt) was linearized by XbaI, and a 328-bp antisense riboprobe was transcribed by T3 RNA polymerase (Promega Corp.), resulting in a protected fragment of 288 bp. A fragment spanning nt 910-1093 of GenBank accession no. U01841 and encoding the partial D and E/F domain of mPPAR␥ was cut off of a pCMV-mPPAR␥ vector and subcloned into the HindIII/SmaI sites of pBluescript KS ϩ vector (Stratagene). An antisense riboprobe of 237 bp was transcribed by T7 RNA polymerase (Promega Corp.) from the recombinant plasmid pBSmPPAR␥ (185 nt) linearized by HindIII, yielding a protected fragment of 185 bp. To assess mouse L27 mRNA expression we used the rat pBS-L27 (150 nt) probe described above.
For all PPAR probes, a 1:1 ratio of [␣-32 P]UTP (800 Ci/mmol) to cold UTP was used, whereas a 1:20 ratio was used for the L27 probe. Labeled probes were precipitated by trichloroacetic acid on GM filters (Whatman, Clifton, NJ) to determine radioisotope incorporation, which was typically between 60 -70%. Filters were counted using an automatic liquid scintillation system (Kontron Instruments Ltd., Zurich, Switzerland), and specific activities were calculated. In pilot experiments, each probe was hybridized with increasing amounts of sample RNA (5-40 g), ensuring that 1 ng specific PPAR probes and 10 ng L27 probe provided a molar excess of probe vs. target RNA up to the maximal amount of RNA tested.
RNA preparation and RNase protection assay
Eight-to 9-wk-old male Sprague Dawley (ϳ200 g) rats were purchased from RCC BRL (Basel, Switzerland). Eight-to 12-wk-old male pure-bred wild-type or PPAR␣ null mice on an Sv129 background were obtained from Dr. Frank Gonzalez (10) . Rats and mice were housed with a 12-h light, 12-h dark cycle beginning at 0700 h and free access to water and standard laboratory chow. For the fasting experiment, food was removed at 1900 h. Access to water remained free, and animals were killed the following day at 0700 h. In the refeeding experiment, food was reintroduced after 7.5 h of fasting. Dexamethasone was injected into rats at 40 g/kg BW, and rats were killed 4 h later. Animals were anesthetized with Forene (Abbott Laboratories, Chicago, IL), killed by decapitation, and rapidly dissected. Tissues were directly frozen in TRIzol (Life Technologies, Inc., Grand Island, NY) by liquid nitrogen and kept at Ϫ70 C until RNA preparation. Tissues were homogenized with a Polytron homogenizer (Kinematica, Lucerne, Switzerland), and total RNA was prepared with TRIzol following the instructions of the provider. The RNase protection assay was carried out as previously described (11) . Approximately 15 g total RNA were hybridized to 1 ng specific PPAR probes each (2 ϫ 10 9 cpm/g) and 10 ng L27 probe (1 ϫ 10 8 cpm/g). RNase digestion [RNase A, Sigma (St. Louis, MO); RNase T1, Life Technologies, Inc.] was carried out for all the probes at 30 C. Gels were exposed on phosphor screens of a StormImager 840 (Molecular Dynamics, Inc., Sunnyvale, CA). IQuant 2.5 software (Molecular Dynamics, Inc.) was used for quantification by drawing a line per lane and removing background. PPAR mRNA expression was normalized to the previously calculated specific activity of the probe and to L27 mRNA expression. The PPAR/L27 ratio was further normalized to the UTP content of each PPAR probe. sd values were calculated with Excel software (Microsoft Corp., Redmond, VA) and Cricket Graph software (Computer Associates, Islandia, NY) used for diagrams.
All animal experimentation was approved by the commission of the Etat de Vaud (Switzerland) for authorization of live animal experimentation.
Western blot analysis
Nuclear extracts of rat liver were prepared as follows. One gram of rat liver was frozen in liquid nitrogen and crushed with a hammer. Tissues were further homogenized in 5 ml of a 0.5 m sucrose, 50 mm Tris-HCl (pH 7.5), 1 mm EDTA, and 25 mm KCl solution in a glass-Teflon homogenizer. Cells were then lysed with 0.5% Triton X-100 for 30 min at 4 C. The homogenate was layered on a 0.9 m sucrose, 50 mm Tris-HCl (pH 7.5), 1 mm EDTA, and 25 mm KCl solution. After centrifugation at 1800 ϫ g for 20 min, pelleted nuclei were resuspended in 40% glycerol, 50 mm Tris-HCl (pH 8), 5 mm MgCl 2 , and 0.1 mm EDTA and stored at Ϫ70 C. The protein concentration was determined by measuring absorbance at 230 and 260 nm. Thirty-five micrograms of proteins were separated by SDS-PAGE and blotted on a BA85 Protrane membrane (Schleicher & Schuell, Inc., Keene, NH). PPAR␤ antibody was raised against the first 15 N-terminal amino acids of mPPAR␤ (peptide sequence: MEQPQEETPEAREEEC). Blots were blocked for 1 h at 37 C with 5% nonfat dry milk in 25 mm Tris-HCl (pH 8.0), 140 mm NaCl, 2 mm KCl, and 0.05% Tween 20 (NFDM TBS-Tween) and washed twice for 10 min each time in TBS-Tween. Primary antibody was incubated for 4 h at a final concentration of approximately 2 g/ml in 0.5% NFDM TBSTween, and blots were washed twice for 10 min each time in 0.5% NFDM TBS-Tween. A secondary goat antirabbit IgG peroxidase-conjugated antibody was incubated for 1 h at a dilution of 1:3000 in 0.5% NFDM TBS-Tween, and blots were washed twice for 10 min each time in 0.5% NFDM TBS-Tween and twice for 30 min each time in 5% NFDM TBSTween. Immunodetection and chemiluminescence were performed according to the manufacturer's protocol (ECL, Amersham Pharmacia Biotech), and membranes were exposed on Kodak films. Signals were quantified using an Elscript 400-AT/SM densitometer (Hirschmann, Neuried, Germany).
Results
Cloning and sequencing of rat PPAR cDNAs
First, we cloned and sequenced all three rat PPAR isotype cDNAs, including that of the PPAR␥2 isoform, to have access to adequate probes for further mRNA expression studies. The sequence of rPPAR␣ is identical to that reported previously (26 (27, 28) . As our sequence is based on two independent RT-PCR reactions for both rPPAR␥1 and rPPAR␥2, a polymorphism at this site in exon 2 of the ppar␥ gene may therefore exist.
PPAR expression in rat tissues
PPAR mRNA expression for each of the three PPAR isotypes was quantified by RNase protection assay in 22 different organs of the adult rat. All experiments were performed so as to allow a comparison of the relative levels between the different tissues and between the different isotypes (see Materials and Methods).
In nearly all tissues analyzed, PPAR␤ is the most abundant isotype, with its highest expression levels in the digestive tract, kidney, heart, diaphragm, and esophagus ( Figs. 1 and  2B) . In comparison to the highest levels in the digestive tract, PPAR␤ expression is about 4 -5 times lower in all of the other organs analyzed. PPAR␣ is highly expressed in brown adipose tissue (BAT), at about 4 times the levels observed in liver, heart, diaphragm, esophagus, and kidney ( Figs. 1 and  2A) . It is indeed the highest PPAR level regardless of the isotype or tissue considered (Fig. 2) . With respect to its expression in liver, PPAR␣ is expressed at about 3-fold lower levels in small intestine, bladder (data not shown), and skeletal muscle. In all other tissues, including WAT, PPAR␣ mRNA remains detectable, but at low levels. In the digestive tract, PPAR␣ mRNA expression decreases from the duodenum and ileum toward the rectum. PPAR␥1 is highly expressed in both WAT and BAT at levels comparable to those of PPAR␣ mRNA in BAT and PPAR␤ mRNA in the digestive tract (Figs. 1 and 2C ). PPAR␥1 is expressed in colon and cecum at about 3-fold lower levels than in adipose tissue. PPAR␥1 expression in spleen, stomach, rectum, lung, and heart is about 10 times lower than that in adipose tissue and at least 25 times lower in small intestine, testis, kidney, and liver. The presence of both PPAR␥ isoforms has been consistently found in lung, WAT, BAT, and skeletal muscle, and the relative amount of PPAR␥2 mRNA vs. total PPAR␥ mRNA is, respectively, 33%, 30%, 18%, and 32% (Figs. 1  and 2D ).
We also analyzed rat tissues of three female rats and compared the PPAR mRNA levels between male and female animals (data not shown). No tissue showed a genderspecific PPAR mRNA expression pattern.
PPAR mRNA expression during fasting
We compared the mRNA expression of all three PPAR isotypes in overnight-fasted male adult rats with that of their fed counterparts. In an attempt to synchronize the feeding status, food was removed at the end of the daylight hours, when rats do not feed extensively. The rats were killed after a 12-h fast at the end of the dark cycle.
Strikingly, we observed a dramatic decrease in PPAR␤ mRNA in the liver and kidney by, respectively, 75% and 80% (Fig. 2B) . In none of the other analyzed tissues did we observe any statistically significant variations in PPAR␤ mRNA levels (Fig. 2B) . PPAR␣ mRNA levels increase in the liver during fasting as previously reported (13) (Fig. 2A) . We also observed a statistically significant increase in PPAR␣ expression in duodenum, jejunum, and colon by 40%, 57%, and 20%, respectively, and a marked increase in the ileum by 38%. A significant increase in PPAR␣ expression was also found in the thymus, where absolute PPAR␣ expression is very low (Fig. 2A) . Interestingly, PPAR␥2 mRNA levels decreased in WAT and BAT by up to 50% during fasting (Fig.  2D) , whereas PPAR␥1 showed only a weak regulation during fasting, with a decreased mRNA expression level that was only significant in the ileum (Fig. 2C) .
Nutritional regulation of PPAR␤ mRNA expression in liver and kidney
We then performed a refeeding experiment to study the potential regulation of hepatic and renal PPAR␤ mRNA expression by food intake. The experiment started at the end of the daylight hours. The group of refed rats was first fasted for 7.5 h and then had free access to food for 4.5 h before mRNA levels were measured. Control groups in this experiment comprised fed rats and rats fasted for 7.5 and 12 h (7.5 plus 4.5 h), respectively. We assessed PPAR␣ and PPAR␤ mRNA expression by RNase protection assay in liver, kidney, heart, and WAT (Fig. 3A) . Again, we observed in both liver and kidney a dramatic decrease in PPAR␤ mRNA expression after both 7.5 and 12 h of fasting by up to 70% (P Ͻ 0.05; Fig. 3B ). Refeeding for 4.5 h after a 7.5-h fast was sufficient to restore PPAR␤ mRNA expression to the level observed in fed animals (Fig. 3B) . Concomitant to the decrease in mRNA levels, PPAR␤ protein abundance also decreased by about 30% during fasting, as assessed by a semiquantitative Western blot on liver nuclear extracts (Fig. 4) .
As a positive control of PPAR mRNA regulation during fasting, we assessed PPAR␣ mRNA expression in liver, kidney, and heart (Fig. 3A) . We again observed a significant more than 2.5-fold increase in PPAR␣ mRNA gene expres-
Comparative analysis of PPAR␣, PPAR␤, and PPAR␥ expression in 22 organs. A, RNase protection assay. rPPAR␣ and rPPAR␤ mRNA expression (top panel) and rPPAR␥ mRNA expression (bottom panel) detected by RNase protection assay using total rat RNA samples from different organs. Fifteen micrograms of total RNA were used per RNase protection assay, and the samples were separated on a 6% polyacrylamide sion during fasting in the liver (P Ͻ 0.05; Fig. 3C ). Renal and cardiac PPAR␣ mRNA expression levels were not increased in a significant manner (P Ͼ 0.05; Fig. 3C ).
Nutritional hepatic regulation of PPAR␤ is independent of PPAR␣
To further understand the opposite regulation of PPAR␣ and PPAR␤ mRNA expression in liver during fasting, we used PPAR␣-null mutant mice to investigate whether the observed tight nutritional regulation of hepatic PPAR␤ gene expression is dependent on PPAR␣ activity. The design of specific mouse PPAR probes allowed us to assess PPAR␤ mRNA expression in wild-type and mutant mice by RNase protection assay (Fig. 5A) . After an overnight fast, we observed a similar decrease in hepatic PPAR␤ mRNA expression in wild-type and PPAR␣ null-mutant mice by up to 80% (Fig. 5B) . Thus, nutritional regulation of hepatic PPAR␤ mRNA expression by fasting is independent of the activity of PPAR␣. A parallel analysis of PPAR␥ mRNA expression by RNase protection showed similar expression levels of this latter subtype in both wild-type and mutant mice, thus excluding compensatory effects of the PPAR␥ isotype in the absence of PPAR␣ (data not shown).
Finally and in contrast to PPAR␣ (13), the regulation of gel. The protected fragments have a size of 287 nt for rPPAR␣, 171 nt for rPPAR␤, 257 nt for rPPAR␥1, and 351 nt for rPPAR␥2. Ribosomal protein L27 was used as an internal standard. Representative results of different experiments or different exposure times are presented. PPAR and L27 protected fragments are indicated by arrows. B, Histograms show quantifications (in relative values) of PPAR mRNA levels Ϯ SD, normalized to L27 mRNA expression, derived from RNase protection assays such as that illustrated in A. Relative PPAR mRNA expression levels are drawn so as to allow comparison between different isotypes and organs. n ϭ 5 for liver, heart, kidney, brain, and WAT; n ϭ 3 for all other tissues. sem. vesicle, Seminal vesicle; sk. Muscle, skeletal muscle.
FIG. 2.
PPAR mRNA expression during fasting in adult rat tissues. Fifteen micrograms of total RNA from fed and overnight-fasted adult rat tissues were analyzed for PPAR mRNA expression by RNase protection assay. After RNase digestion, the samples were separated on a 6% polyacrylamide gel, as illustrated in Fig. 1 . Histograms show quantifications (in relative values) of PPAR mRNA levels Ϯ SD, normalized to L27 mRNA expression, derived from RNase protection assays such as that illustrated in Fig. 3 . Relative PPAR mRNA expression levels are drawn so as to allow comparison between different isotypes and organs (see Materials and Methods). A, PPAR␣ mRNA expression; B, PPAR␤ mRNA expression; C, PPAR␥1 mRNA expression; D, PPAR␥2 mRNA expression. n ϭ 5 for liver, heart, kidney, brain, and WAT; n ϭ 3 for all other tissues. skel. Muscle, Skeletal muscle. *, P Ͻ 0.05; **, P Ͻ 0.01 (by t test).
hepatic PPAR␤ mRNA expression levels by fasting and refeeding is independent of plasma glucocorticoid levels, as injection of the synthetic glucocorticoid dexamethasone had no effect on hepatic PPAR␤ mRNA expression (data not shown).
Discussion
PPAR␤ is predominantly expressed in the digestive tract and in organs with high fatty acid oxidation
The present study gives new insight into the physiological function of PPAR␤. PPAR␤ is the most abundant isotype in all adult rat tissues analyzed, except adipose tissue. Previous in situ hybridization studies showed that PPAR␤ is highly expressed in proliferating embryonic tissues (29) . High PPAR␤ expression in the digestive tract may therefore be linked to ongoing cell proliferation and differentiation processes in the adult gut. Indeed, enterocytes have a high turnover of 3-6 d in the small intestine and 5-8 d in the large intestine (30) . Interestingly, PPAR␤ has been identified as a ␤-catenin/Tcf-4 target gene in humans, like other growth-promoting genes, such as c-myc and cyclin D1 (21) .
The predominant expression of PPAR␤ in intestine also suggests a potential role for this isotype in processes linked to food intake and lipid metabolism. The mucosa of the small intestine resorbs diet lipids that enterocytes transport via the cytosolic fatty acid-binding proteins toward the smooth endoplasmic reticulum to resynthesize lipids and triglycerides (30) . In stomach, where no resorption of nutrients occurs, PPAR␤ expression is about 2 times lower than that in intestine. A recent report using the PPAR␤-selective ligand GW2433 in PPAR␣-null mutant mice shows that the high levels of PPAR␤ present in the small intestine are sufficient to trans-activate the liver fabp gene, which is a PPAR␣ target gene in the liver (31) . PPAR␤ may therefore regulate the intestinal expression of other PPAR target genes implicated in lipid metabolism for which a PPAR␣-dependent transactivation has been previously observed in liver.
The potential role of PPAR␤ in metabolism is further underscored by our observation that tissues with high metabolic rate, such as liver, kidney, and oxidative muscles, also express PPAR␤ mRNA at high levels. Among muscular tissues, we observe a concomitant decrease in PPAR␣ and PPAR␤ expression with decreasing importance of fatty acid oxidation, i.e. skeletal muscle and bladder show lower expression levels of both PPAR␣ and PPAR␤ compared to heart and diaphragm. Taken together, these observations suggest FIG. 3 . PPAR mRNA expression in fasting and refeeding. A, Fifteen micrograms of total liver, kidney, heart, and WAT RNA were analyzed by RNase protection assay for PPAR␣ and PPAR␤ mRNA expression. After RNase digestion, the samples were separated on a 6% polyacrylamide gel. Adult rats were fasted for 7.5 h (lanes 1-3) or 12 h (lanes 10 -12), control animals were fed ad libitum overnight (lanes 4 -6), and refed animals were fasted for 7.5 h, then ad libitum feeding was reintroduced for 4.5 h before killing the animals (lanes 7-9) . B, Histogram of PPAR␤ mRNA expression in liver, kidney, heart, and WAT standardized to L27 expression. The mean of three animals Ϯ SD are shown. C, Histogram of PPAR␣ mRNA expression in liver, kidney, and heart standardized to L27 expression. The mean of three animals Ϯ SD are shown.
that in tissues where fatty acid oxidation is used for energy production, a link between PPAR␤ and the necessary high lipid metabolism may exist.
Fasting specifically up-regulates hepatic and intestinal PPAR␣ expression
Among all tissues analyzed, only the liver and small intestine show increased PPAR␣ mRNA expression during fasting. The high fasting PPAR␣ mRNA levels observed in the liver underline the prominent role of this isotype in hepatic lipid metabolism. Up-regulation of hepatic PPAR␣ expression and subsequent activation of the PPAR␣ target genes implicated in hepatic fatty acid oxidation (i.e. mitochondrial ␤-oxidation, microsomal -hydroxylation, and peroxisomal ␤-oxidation) are critical events in the adaptive response to fasting (16, 17, 32) . In addition to the liver, PPAR␣ induces cardiac fatty acid oxidation during fasting (17) . Interestingly, we observed no increase in PPAR␣ mRNA expression during fasting in this oxidative muscle. In kidney also, PPAR␣ mRNA expression is not markedly increased, although fatty acids are efficiently oxidized in the renal cortex. These results are in line with the observation that clofibrate-fed rats show an increase in cortical expression of mitochondrial and peroxisomal PPAR␣ target genes, whereas no significant change in PPAR␣ mRNA itself is observed (33) .
Interestingly, GR mRNA levels are comparable in liver, kidney, and heart (34), but corticosteroids do not modulate its expression in the two latter tissues (35) . Additional experiments will be necessary to determine whether the GRs present in the intestinal epithelium (36) mediate the observed increase in intestinal PPAR␣ mRNA expression.
Nutritional regulation of PPAR␤ mRNA expression
An important finding of this study is the dramatic decrease in hepatic and renal PPAR␤ mRNA expression during fasting, which is rapidly restored to control levels by refeeding. In agreement with a regulation of PPAR␤ by food intake and in addition to our results, a recent report shows that PPAR␤ mRNA expression levels remain low after a 72-h fast (37) . We observe a general tendency toward decreased PPAR␤ mRNA levels during fasting in all analyzed tissues, but the tight regulation by feeding status in liver and kidney suggests a tissue-specific mechanism of PPAR␤ regulation. Our results show that PPAR␤ regulation during fasting is independent of plasma glucocorticoid hormone levels and PPAR␣ activity. Also, the abnormally elevated plasma FFA concentrations observed in the PPAR␣-null mutant mice (16) do not alter the expression of PPAR␤ compared with that in wildtype mice. Thus, serum lipid levels alone are not sufficient for the nutritional regulation of PPAR␤. The observation that PPAR␤ is down-regulated in both the liver and kidney, but PPAR␣ is up-regulated only in the liver, further suggests different regulatory mechanisms involved in the expression of these two PPAR isotypes during fasting.
The similar regulation of PPAR␤ expression in the liver and kidney may be related to metabolic fates common to these two tissues, e.g. gluconeogenesis and lipogenesis. As gluconeogenesis is increased during fasting, PPAR␤ would be a negative regulator of this pathway. Interestingly, sterol regulatory element-binding protein-1c/adipocyte determination differentiation-dependent factor-1 shows a similar expression pattern as PPAR␤ during fasting and refeeding (38, 39) . This transcription factor is induced by food intake and mediates the expression of lipogenic genes induced by glucose and insulin (40) . Further studies will be necessary to determine whether PPAR␤ is implicated in sensing serum carbohydrate levels and is targeted by hormonal signaling leading to lipogenesis.
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